Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.36 USD | 0.00% | -9.05% | +19.77% |
Apr. 12 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
Apr. 12 | Sector Update: Health Care | MT |
Financials (USD)
Sales 2024 * | 71.27M | Sales 2025 * | 66.83M | Capitalization | 733M |
---|---|---|---|---|---|
Net income 2024 * | -171M | Net income 2025 * | -221M | EV / Sales 2024 * | 6.13 x |
Net cash position 2024 * | 297M | Net cash position 2025 * | 295M | EV / Sales 2025 * | 6.56 x |
P/E ratio 2024 * |
-4.15
x | P/E ratio 2025 * |
-3.7
x | Employees | 284 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.8% |
1 week | -9.05% | ||
Current month | -15.92% | ||
1 month | -14.99% | ||
3 months | +57.25% | ||
6 months | +180.91% | ||
Current year | +19.77% |
Managers | Title | Age | Since |
---|---|---|---|
Arthur Sands
CEO | Chief Executive Officer | 62 | 14-09-17 |
Hans van Houte
DFI | Director of Finance/CFO | 58 | 14-12-31 |
Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Judith Reinsdorf
BRD | Director/Board Member | 60 | 21-09-30 |
Paul Silva
BRD | Director/Board Member | 58 | 21-09-30 |
Arthur Sands
CEO | Chief Executive Officer | 62 | 14-09-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.70% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 12.36 | 0.00% | 599,965 |
24-04-25 | 12.36 | -10.11% | 966,502 |
24-04-24 | 13.75 | -2.69% | 519,873 |
24-04-23 | 14.13 | +4.05% | 895,076 |
24-04-22 | 13.58 | -0.07% | 574,496 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.77% | 733M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- NRIX Stock